Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Marksans Pharma: Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30 September 2025
News Announcement

Marksans Pharma: Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30 September 2025

13-Nov-2025 Follow Value Research Online on Google download pdfDownload PDF Marksans Pharma

Approval of Unaudited Financial Results both standalone and consolidated for the quarter and half year ended 30 September 2025.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds